Interventions such as EGF inhibition using short hairpin RNA (sh-EGF) and anti-miR-21 oligonucleotides suppress inflammation and epithelial remodeling, offering a novel strategy for managing CRSwNP [19]. The gene discussed is EGF; the disease is chronic rhinosinusitis with nasal polyps.